During the past decade, Centre Hospitalier de Dreux conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Dreux" #1 sponsor was "AB Science" with 2 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Hopital Foch" with 2 trials sponsored and "University Hospital, Angers" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Dreux" #1 collaborator was "Ministry of Health, France" with 2 trials as a collaborator, "CHU Nantes" with 1 trials as a collaborator, "Grupo Espanol de Investigacion en Sarcomas" with 1 trials as a collaborator, "Italian Sarcoma Group" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Dreux" are "Colorectal Cancer" (4 trials), "Chronic Hepatitis C" (2 trials), "Pancreatic Cancer" (2 trials), "ALK Gene Mutation" (1 trials) and "Anesthesia" (1 trials). Many other conditions were trialed in "Centre Hospitalier de Dreux" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Dreux" are "Drug" (12 trials), "Device" (4 trials), "Other" (4 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Masitinib" (2 trials), "Placebo" (2 trials), "fluorouracil" (2 trials), "leucovorin calcium" (2 trials) and "oxaliplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Dreux" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Dreux". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Centre Hospitalier de Dreux, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Dreux, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".